A vaccine that slows the progression of Alzheimer’s disease and other types of dementia has been developed by Sydney researchers. The vaccine, which targets a protein known as tau, prevents the ongoing formation of neurofibrillary tangles in the brain of a mouse with Alzheimer’s disease.
This progressive neurodegenerative disease affects more than 35 million people worldwide. The tau protein is also involved in front temporal dementia, the second most common form of dementia in people younger than 65 years.
A/Prof Lars Ittner, Brain and Mind Research Institute, University of Sydney
PLoS ONE
http://sydney.edu.au/news/84.html?newscategoryid=1&newsstoryid=8384